🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/12/1997 | 44,92 | 44,92 | 43,04 | 43,51 | -2,11% | 4,17% | 40.075 |
| 23/12/1997 | 44,68 | 45,85 | 44,45 | 44,45 | -0,78% | 3,14% | 41.972 |
| 22/12/1997 | 44,92 | 45,15 | 43,98 | 44,80 | +0,79% | 2,60% | 25.862 |
| 19/12/1997 | 45,38 | 45,62 | 42,11 | 44,45 | -3,06% | 7,73% | 104.168 |
| 18/12/1997 | 47,26 | 47,96 | 44,92 | 45,85 | -3,45% | 6,44% | 92.306 |
| 17/12/1997 | 48,19 | 48,66 | 47,26 | 47,49 | -1,93% | 2,91% | 75.768 |
| 16/12/1997 | 49,59 | 50,06 | 48,19 | 48,42 | -0,96% | 3,77% | 75.955 |
| 15/12/1997 | 49,13 | 50,06 | 48,66 | 48,89 | -0,95% | 2,86% | 74.326 |
| 12/12/1997 | 50,06 | 51,00 | 49,13 | 49,36 | -1,86% | 3,74% | 34.411 |
| 11/12/1997 | 52,17 | 52,40 | 49,59 | 50,30 | -3,15% | 5,38% | 115.336 |
| 10/12/1997 | 51,93 | 52,40 | 51,00 | 51,93 | +0,00% | 2,70% | 117.847 |
| 09/12/1997 | 52,40 | 53,10 | 51,47 | 51,93 | -0,45% | 3,13% | 119.664 |
| 08/12/1997 | 51,93 | 53,10 | 51,47 | 52,17 | +0,45% | 3,15% | 72.562 |
| 05/12/1997 | 51,47 | 51,93 | 50,06 | 51,93 | +0,91% | 3,64% | 41.544 |
| 04/12/1997 | 51,00 | 52,40 | 50,53 | 51,47 | +0,92% | 3,67% | 42.640 |
| 03/12/1997 | 51,47 | 51,47 | 50,06 | 51,00 | +0,00% | 2,73% | 30.003 |
| 02/12/1997 | 49,13 | 51,47 | 48,66 | 51,00 | +3,32% | 5,71% | 58.990 |
| 01/12/1997 | 48,66 | 50,53 | 47,26 | 49,36 | +3,43% | 6,73% | 50.174 |
| 28/11/1997 | 48,19 | 48,66 | 47,26 | 47,72 | +0,99% | 2,91% | 47.636 |
| 26/11/1997 | 48,66 | 48,66 | 46,79 | 47,26 | +0,00% | 3,85% | 62.891 |
| 25/11/1997 | 50,53 | 50,53 | 46,79 | 47,26 | -3,81% | 7,41% | 56.319 |
| 24/11/1997 | 51,93 | 52,40 | 48,66 | 49,13 | -5,83% | 7,21% | 52.178 |
| 21/11/1997 | 51,93 | 52,40 | 51,47 | 52,17 | +1,36% | 1,80% | 15.790 |
| 20/11/1997 | 51,93 | 52,40 | 51,47 | 51,47 | -0,90% | 1,80% | 24.793 |
| 19/11/1997 | 51,47 | 52,40 | 50,76 | 51,93 | -1,33% | 3,18% | 20.492 |
| 18/11/1997 | 54,27 | 54,27 | 52,17 | 52,64 | +0,00% | 3,88% | 40.022 |
| 17/11/1997 | 52,87 | 53,81 | 52,40 | 52,64 | +0,45% | 2,66% | 35.186 |
| 14/11/1997 | 52,75 | 53,34 | 49,83 | 52,40 | +1,82% | 6,65% | 57.307 |
| 13/11/1997 | 52,87 | 53,34 | 51,47 | 51,47 | -1,79% | 3,54% | 41.384 |
| 12/11/1997 | 55,21 | 55,21 | 51,47 | 52,40 | -4,27% | 6,78% | 63.826 |